Reckitt Benckiser Group (OTCMKTS:RBGLY) Shares Gap Down – Should You Sell?

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) gapped down before the market opened on Tuesday. The stock had previously closed at $14.74, but opened at $13.98. Reckitt Benckiser Group shares last traded at $13.97, with a volume of 10,448 shares traded.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. The Goldman Sachs Group upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. Jefferies Financial Group raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Tuesday, July 21st. Zacks Research upgraded Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a report on Friday, August 28th. Finally, BNP Paribas Exane lowered Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a research note on Wednesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy”.

Check Out Our Latest Research Report on Reckitt Benckiser Group

Reckitt Benckiser Group Price Performance

The stock’s 50-day simple moving average is $13.85 and its 200 day simple moving average is $14.21. The company has a current ratio of 0.59, a quick ratio of 0.40 and a debt-to-equity ratio of 1.31.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc, now operating under the Reckitt name, is a global consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets branded products intended to support personal health, household cleanliness and everyday hygiene.

Its portfolio includes consumer health brands such as Nurofen, Strepsils, Gaviscon, Mucinex and Durex, as well as hygiene and household brands including Dettol, Lysol, Finish and Harpic. Reckitt sells products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other distribution channels.

The company was formed in 1999 through the merger of the British household-products manufacturer Reckitt & Colman and the Dutch company Benckiser.

Featured Stories

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.